Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer
Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds
Mesothelioma Survival, QOL Improved With Alimta, Platinol
NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps
Study Finds Green Tea No Help In Advanced Prostate Cancer
Cancer Screening Priorities Questioned In Dartmouth Study
Regular NSAIDs Use Protects Smokers From Lung Cancer
Women Are Less Active After A Diagnosis of Breast Cancer
NCI-Approved Protocols Listed
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
